Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robyn G. Midwinter is active.

Publication


Featured researches published by Robyn G. Midwinter.


Arteriosclerosis, Thrombosis, and Vascular Biology | 2009

Heme oxygenase-1 increases endothelial progenitor cells.

Ben J. Wu; Robyn G. Midwinter; Carlos Cassano; Konstanze Beck; Yutang Wang; Dechaboon Changsiri; Jennifer R. Gamble; Roland Stocker

Objectives—Induction of heme oxygenase-1 (HO-1) protects against atherosclerotic disease in part by promoting reendothelialization. As endothelial progenitor cells (EPCs) contribute to reendothelialization, we examined the role of HO-1 on bone marrow and circulating EPCs. Methods and Results—In a rabbit model of aortic balloon injury, pharmacological induction of HO-1 enhanced reendothelialization at sites with and without adjacent blood vessels, the latter indicative of a contribution by EPCs. Coinciding with maximal HO-1 induction in the injured vessel, plasma concentrations of bilirubin and the numbers of circulating progenitor cells were elevated. Both processes were abolished by cotreatment of the animals with an inhibitor of HO-1. Inducers of HO-1 promoted bone marrow cells to form progenitor cell colonies, and Flk1+/Sca-1+-cells to adhere to the luminal surface of the injured vessel. In noninjured mice, HO-1 inducers also increased bone marrow and circulating EPCs, and the ability of these cells to differentiate and form colonies. Compared to wild-type mice, bone marrow cells from HO-1−/− mice generated fewer endothelial colony-forming cells, and HO-1 inducers failed to promote CFU-Hill colony formation. Conclusions—These findings suggest that HO-1 contributes to vascular repair by increasing circulating EPCs derived from the bone marrow.


Antioxidants & Redox Signaling | 2014

New Insights into Intracellular Locations and Functions of Heme Oxygenase-1

Louise L. Dunn; Robyn G. Midwinter; Jun Ni; Hafizah A. Hamid; Christopher R. Parish; Roland Stocker

SIGNIFICANCE Heme oxygenase-1 (HMOX1) plays a critical role in the protection of cells, and the inducible enzyme is implicated in a spectrum of human diseases. The increasing prevalence of cardiovascular and metabolic morbidities, for which current treatment approaches are not optimal, emphasizes the necessity to better understand key players such as HMOX1 that may be therapeutic targets. RECENT ADVANCES HMOX1 is a dynamic protein that can undergo post-translational and structural modifications which modulate HMOX1 function. Moreover, trafficking from the endoplasmic reticulum to other cellular compartments, including the nucleus, highlights that HMOX1 may play roles other than the catabolism of heme. CRITICAL ISSUES The ability of HMOX1 to be induced by a variety of stressors, in an equally wide variety of tissues and cell types, represents an obstacle for the therapeutic exploitation of the enzyme. Any capacity to modulate HMOX1 in cardiovascular and metabolic diseases should be tempered with an appreciation that HMOX1 may have an impact on cancer. Moreover, the potential for heme catabolism end products, such as carbon monoxide, to amplify the HMOX1 stress response should be considered. FUTURE DIRECTIONS A more complete understanding of HMOX1 modifications and the properties that they impart is necessary. Delineating these parameters will provide a clearer picture of the opportunities to modulate HMOX1 in human disease.


Advances in Hematology | 2011

Heme Oxygenase-1: A Critical Link between Iron Metabolism, Erythropoiesis, and Development

Stuart T. Fraser; Robyn G. Midwinter; Birgit S. Berger; Roland Stocker

The first mature cells to arise in the developing mammalian embryo belong to the erythroid lineage. This highlights the immediacy of the need for red blood cells during embryogenesis and for survival. Linked with this pressure is the necessity of the embryo to obtain and transport iron, synthesize hemoglobin, and then dispose of the potentially toxic heme via the stress-induced protein heme oxygenase-1 (HO-1, encoded by Hmox1 in the mouse). Null mutation of Hmox1 results in significant embryonic mortality as well as anemia and defective iron recycling. Here, we discuss the interrelated nature of this critical enzyme with iron trafficking, erythroid cell function, and embryonic survival.


Haematologica | 2015

Heme oxygenase-1 deficiency alters erythroblastic island formation, steady-state erythropoiesis and red blood cell lifespan in mice

Stuart T. Fraser; Robyn G. Midwinter; Lucy A. Coupland; Stephanie Kong; Birgit S. Berger; Jia Hao Yeo; Osvaldo Cooley Andrade; Deborah Cromer; Cacang Suarna; Magdalena Lam; Ghassan J. Maghzal; Beng H. Chong; Christopher R. Parish; Roland Stocker

Heme oxygenase-1 is critical for iron recycling during red blood cell turnover, whereas its impact on steady-state erythropoiesis and red blood cell lifespan is not known. We show here that in 8- to 14-week old mice, heme oxygenase-1 deficiency adversely affects steady-state erythropoiesis in the bone marrow. This is manifested by a decrease in Ter-119+-erythroid cells, abnormal adhesion molecule expression on macrophages and erythroid cells, and a greatly diminished ability to form erythroblastic islands. Compared with wild-type animals, red blood cell size and hemoglobin content are decreased, while the number of circulating red blood cells is increased in heme oxygenase-1 deficient mice, overall leading to microcytic anemia. Heme oxygenase-1 deficiency increases oxidative stress in circulating red blood cells and greatly decreases the frequency of macrophages expressing the phosphatidylserine receptor Tim4 in bone marrow, spleen and liver. Heme oxygenase-1 deficiency increases spleen weight and Ter119+-erythroid cells in the spleen, although α4β1-integrin expression by these cells and splenic macrophages positive for vascular cell adhesion molecule 1 are both decreased. Red blood cell lifespan is prolonged in heme oxygenase-1 deficient mice compared with wild-type mice. Our findings suggest that while macrophages and relevant receptors required for red blood cell formation and removal are substantially depleted in heme oxygenase-1 deficient mice, the extent of anemia in these mice may be ameliorated by the prolonged lifespan of their oxidatively stressed erythrocytes.


Free Radical Biology and Medicine | 2012

Succinobucol induces apoptosis in vascular smooth muscle cells

Robyn G. Midwinter; Ghassan J. Maghzal; Joanne M. Dennis; Ben J. Wu; Hong Cai; Alexandr A. Kapralov; Natalia A. Belikova; Yulia Y. Tyurina; Lan-Feng Dong; Levon M. Khachigian; Jiri Neuzil; Valerian E. Kagan; Roland Stocker

Probucol inhibits the proliferation of vascular smooth muscle cells in vitro and in vivo, and the drug reduces intimal hyperplasia and atherosclerosis in animals via induction of heme oxygenase-1 (HO-1). Because the succinyl ester of probucol, succinobucol, recently failed as an antiatherogenic drug in humans, we investigated its effects on smooth muscle cell proliferation. Succinobucol and probucol induced HO-1 and decreased cell proliferation in rat aortic smooth muscle cells. However, whereas inhibition of HO-1 reversed the antiproliferative effects of probucol, this was not observed with succinobucol. Instead, succinobucol but not probucol induced caspase activity and apoptosis, and it increased mitochondrial oxidation of hydroethidine to ethidium, suggestive of the participation of H(2)O(2) and cytochrome c. Also, succinobucol but not probucol converted cytochrome c into a peroxidase in the presence of H(2)O(2), and succinobucol-induced apoptosis was decreased in cells that lacked cytochrome c or a functional mitochondrial complex II. In addition, succinobucol increased apoptosis of vascular smooth muscle cells in vivo after balloon angioplasty-mediated vascular injury. Our results suggest that succinobucol induces apoptosis via a pathway involving mitochondrial complex II, H(2)O(2), and cytochrome c. These unexpected results are discussed in light of the failure of succinobucol as an antiatherogenic drug in humans.


Archives of Biochemistry and Biophysics | 2001

Hypochlorous Acid Stimulation of the Mitogen-Activated Protein Kinase Pathway Enhances Cell Survival

Robyn G. Midwinter; Margret C. M. Vissers; Christine C. Winterbourn


Free Radical Biology and Medicine | 2004

Chlorine transfer between glycine, taurine, and histamine: reaction rates and impact on cellular reactivity.

Alexander V. Peskin; Robyn G. Midwinter; David T. Harwood; Christine C. Winterbourn


Biochemical Journal | 2006

IκB is a sensitive target for oxidation by cell-permeable chloramines: inhibition of NF-κB activity by glycine chloramine through methionine oxidation

Robyn G. Midwinter; Fook Choe Cheah; Jackob Moskovitz; Margret C. M. Vissers; Christine C. Winterbourn


Journal of Biological Chemistry | 2004

Extracellular Oxidation by Taurine Chloramine Activates ERK via the Epidermal Growth Factor Receptor

Robyn G. Midwinter; Alexander V. Peskin; Margret C. M. Vissers; Christine C. Winterbourn


Archive | 2012

Probucol-Derivatives in the Treatment of Atherosclerosis

Robyn G. Midwinter; Roland Stocker

Collaboration


Dive into the Robyn G. Midwinter's collaboration.

Top Co-Authors

Avatar

Roland Stocker

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar

Louise L. Dunn

Victor Chang Cardiac Research Institute

View shared research outputs
Top Co-Authors

Avatar

M. Ng

Royal Prince Alfred Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ghassan J. Maghzal

Victor Chang Cardiac Research Institute

View shared research outputs
Top Co-Authors

Avatar

Kim H. Chan

Royal Prince Alfred Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Ni

University of Sydney

View shared research outputs
Top Co-Authors

Avatar

M. Guillou

Royal Prince Alfred Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge